デフォルト表紙
市場調査レポート
商品コード
1531002

GI便検査の世界市場:産業分析、規模、シェア、成長、動向、予測、2024~2034年

GI Stool Testing Market (Product Type: Consumables and Analyzers, and Test Type: Occult Blood Test, Ova and Parasites Test, Fecal Biomarkers Test, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


出版日
ページ情報
英文 148 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
GI便検査の世界市場:産業分析、規模、シェア、成長、動向、予測、2024~2034年
出版日: 2024年06月13日
発行: Transparency Market Research
ページ情報: 英文 148 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のGI便検査市場について、2024~2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018~2034年までの世界のGI便検査市場の収益と予測を提供しています。また、2024~2034年までの世界のGI便検査市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、産業リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、GI便検査市場を推察しました。

市場スナップショット
2023年の市場規模 5億5,500万米ドル
2034年の市場規模 13億米ドル
CAGR 7.7%

当レポートでは、世界のGI便検査市場の競合情勢について調査しています。世界のGI便検査市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のGI便検査市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020~2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要合併・買収
  • COVID-19による産業への影響

第6章 世界の市場分析と予測:製品タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測:製品タイプ別、2020~2034年
    • 消耗品
    • アナライザー
  • 市場魅力分析:製品タイプ別

第7章 世界の市場分析と予測:検査タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測:検査タイプ別、2020~2034年
    • 潜血検査
    • 卵子・寄生虫検査
    • 糞便バイオマーカー検査
    • その他(細菌検査等)
  • 市場魅力分析:検査タイプ別

第8章 世界の市場分析と予測:適応症別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測:適応症別、2020~2034年
    • 感染症
    • 炎症性腸疾患
    • 胃食道逆流症
    • がん
    • その他
  • 市場魅力分析:適応症別

第9章 世界の市場分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測:エンドユーザー別、2020~2034年
    • 病院
    • 診断センター・検査室
    • 学術機関
    • 研究センターと組織
    • その他
  • 市場魅力分析:エンドユーザー別

第10章 世界の市場分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2020~2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第11章 北米の市場分析と予測

第12章 欧州の市場分析と予測

第13章 アジア太平洋の市場分析と予測

第14章 ラテンアメリカの市場分析と予測

第15章 中東・アフリカの市場分析と予測

第16章 競合情勢

  • 市場企業-競合マトリックス(企業階層と規模別)
  • 市場シェア分析:企業別(2023年)
  • 企業プロファイル
    • Abbott Laboratories
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories
    • BioMerieux Inc.
    • Cardinal Health, Inc.
    • Cenogenics Corporation
    • Epitope Diagnostics, Inc.
    • ScheBo Biotech AG
    • Quest Diagnostics
    • Genova Diagnostics
図表

List of Tables

  • Table 01: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 02: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 03: Global GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 04: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 05: Global GI Stool Testing Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 08: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 09: North America GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 10: North America GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 13: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 14: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 15: Europe GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 18: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 19: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 20: Asia Pacific GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 23: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 24: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 28: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 29: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global GI Stool Testing Market Size (US$ Mn), by Region, 2023 and 2034
  • Figure 02: Global GI Stool Testing Market Revenue (US$ Mn), by Product Type, 2023
  • Figure 03: Global GI Stool Testing Market Value Share, by Product Type, 2023
  • Figure 04: Global GI Stool Testing Market Revenue (US$ Mn), by Test Type, 2023
  • Figure 05: Global GI Stool Testing Market Value Share, by Test Type, 2023
  • Figure 06: Global GI Stool Testing Market Revenue (US$ Mn), by Indication, 2023
  • Figure 07: Global GI Stool Testing Market Value Share, by Indication, 2023
  • Figure 08: Global GI Stool Testing Market Revenue (US$ Mn), by End-user, 2023
  • Figure 09: Global GI Stool Testing Market Value Share, by End-user, 2023
  • Figure 10: Global GI Stool Testing Market Value Share, by Region, 2023
  • Figure 11: Global GI Stool Testing Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 12: Global GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 13: Global GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 14: Global GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 15: Global GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 16: Global GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 17: Global GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 18: Global GI Stool Testing Market Revenue (US$ Mn), by End-user, 2023
  • Figure 19: Global GI Stool Testing Market Value Share, by End-user, 2023
  • Figure 20: Global GI Stool Testing Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global GI Stool Testing Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America GI Stool Testing Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America GI Stool Testing Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 26: North America GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 27: North America GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 28: North America GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 30: North America GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 31: North America GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 32: North America GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 37: Europe GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 38: Europe GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 39: Europe GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 41: Europe GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 42: Europe GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 43: Europe GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 48: Asia Pacific GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 49: Asia Pacific GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 50: Asia Pacific GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 52: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 53: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 54: Asia Pacific GI Stool Testing Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America GI Stool Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 59: Latin America GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 60: Latin America GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 61: Latin America GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 63: Latin America GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 64: Latin America GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 65: Latin America GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa GI Stool Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 70: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 71: Middle East & Africa GI Stool Testing Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 72: Middle East & Africa GI Stool Testing Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 74: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 75: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 76: Middle East & Africa GI Stool Testing Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86210

GI Stool Testing Market - Scope of Report

TMR's report on the global GI stool testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global GI stool testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global GI stool testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the GI stool testing market.

Market Snapshot
Market Value in 2023US$ 555 Mn
Market Value in 2034US$ 1.3 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global GI stool testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global GI stool testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global GI stool testing market.

The report delves into the competitive landscape of the global GI stool testing market. Key players operating in the global GI stool testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global GI stool testing market profiled in this report.

Key Questions Answered in Global GI stool testing Market Report:

  • What is the sales/revenue generated by GI stool testing across all regions during the forecast period?
  • What are the opportunities in the global GI stool testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

GI Stool Testing Market - Research Objectives and Research Approach

The comprehensive report on the global GI stool testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global GI stool testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global GI stool testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global GI Stool Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global GI Stool Testing Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global GI Stool Testing Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020-2034
    • 6.3.1. Consumables
    • 6.3.2. Analyzers
  • 6.4. Market Attractiveness, by Product Type

7. Global GI Stool Testing Market Analysis and Forecast, by Test Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2034
    • 7.3.1. Occult Blood Test
    • 7.3.2. Ova and Parasites Test
    • 7.3.3. Fecal Biomarkers Test
    • 7.3.4. Others (Bacteria Test, etc.)
  • 7.4. Market Attractiveness, by Test Type

8. Global GI Stool Testing Market Analysis and Forecast, by Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2020-2034
    • 8.3.1. Infection
    • 8.3.2. Inflammatory Bowel Disease
    • 8.3.3. Gastroesophageal Reflux Disease
    • 8.3.4. Cancer
    • 8.3.5. Others (Poor Absorption Problems, etc.)
  • 8.4. Market Attractiveness, by Indication

9. Global GI Stool Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers & laboratories
    • 9.3.3. Academic Institutes
    • 9.3.4. Research Centers & Organizations
    • 9.3.5. Others (Homecare Settings, etc.)
  • 9.4. Market Attractiveness, by End-user

10. Global GI Stool Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America GI Stool Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020-2034
    • 11.2.1. Consumables
    • 11.2.2. Analyzers
  • 11.3. Market Attractiveness, by Product Type
  • 11.4. Market Value Forecast, by Test Type, 2020-2034
    • 11.4.1. Occult Blood Test
    • 11.4.2. Ova and Parasites Test
    • 11.4.3. Fecal Biomarkers Test
    • 11.4.4. Others (Bacteria Test, etc.)
  • 11.5. Market Attractiveness, by Test Type
  • 11.6. Market Value Forecast, by Indication, 2020-2034
    • 11.6.1. Infection
    • 11.6.2. Inflammatory Bowel Disease
    • 11.6.3. Gastroesophageal Reflux Disease
    • 11.6.4. Cancer
    • 11.6.5. Others (Poor Absorption Problems, etc.)
  • 11.7. Market Attractiveness, by Indication
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Diagnostic Centers & laboratories
    • 11.8.3. Academic Institutes
    • 11.8.4. Research Centers & Organizations
    • 11.8.5. Others (Homecare Settings, etc.)
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product Type
    • 11.11.2. By Test Type
    • 11.11.3. By Indication
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe GI Stool Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020-2034
    • 12.2.1. Consumables
    • 12.2.2. Analyzers
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value Forecast, by Test Type, 2020-2034
    • 12.4.1. Occult Blood Test
    • 12.4.2. Ova and Parasites Test
    • 12.4.3. Fecal Biomarkers Test
    • 12.4.4. Others (Bacteria Test, etc.)
  • 12.5. Market Attractiveness, by Test Type
  • 12.6. Market Value Forecast, by Indication, 2020-2034
    • 12.6.1. Infection
    • 12.6.2. Inflammatory Bowel Disease
    • 12.6.3. Gastroesophageal Reflux Disease
    • 12.6.4. Cancer
    • 12.6.5. Others (Poor Absorption Problems, etc.)
  • 12.7. Market Attractiveness, by Indication
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Diagnostic Centers & laboratories
    • 12.8.3. Academic Institutes
    • 12.8.4. Research Centers & Organizations
    • 12.8.5. Others (Homecare Settings, etc.)
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product Type
    • 12.11.2. By Test Type
    • 12.11.3. By Indication
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific GI Stool Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020-2034
    • 13.2.1. Consumables
    • 13.2.2. Analyzers
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value Forecast, by Test Type, 2020-2034
    • 13.4.1. Occult Blood Test
    • 13.4.2. Ova and Parasites Test
    • 13.4.3. Fecal Biomarkers Test
    • 13.4.4. Others (Bacteria Test, etc.)
  • 13.5. Market Attractiveness, by Test Type
  • 13.6. Market Value Forecast, by Indication, 2020-2034
    • 13.6.1. Infection
    • 13.6.2. Inflammatory Bowel Disease
    • 13.6.3. Gastroesophageal Reflux Disease
    • 13.6.4. Cancer
    • 13.6.5. Others (Poor Absorption Problems, etc.)
  • 13.7. Market Attractiveness, by Indication
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Diagnostic Centers & laboratories
    • 13.8.3. Academic Institutes
    • 13.8.4. Research Centers & Organizations
    • 13.8.5. Others (Homecare Settings, etc.)
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product Type
    • 13.11.2. By Test Type
    • 13.11.3. By Indication
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America GI Stool Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020-2034
    • 14.2.1. Consumables
    • 14.2.2. Analyzers
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value Forecast, by Test Type, 2020-2034
    • 14.4.1. Occult Blood Test
    • 14.4.2. Ova and Parasites Test
    • 14.4.3. Fecal Biomarkers Test
    • 14.4.4. Others (Bacteria Test, etc.)
  • 14.5. Market Attractiveness, by Test Type
  • 14.6. Market Value Forecast, by Indication, 2020-2034
    • 14.6.1. Infection
    • 14.6.2. Inflammatory Bowel Disease
    • 14.6.3. Gastroesophageal Reflux Disease
    • 14.6.4. Cancer
    • 14.6.5. Others (Poor Absorption Problems, etc.)
  • 14.7. Market Attractiveness, by Indication
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Diagnostic Centers & laboratories
    • 14.8.3. Academic Institutes
    • 14.8.4. Research Centers & Organizations
    • 14.8.5. Others (Homecare Settings, etc.)
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product Type
    • 14.11.2. By Test Type
    • 14.11.3. By Indication
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa GI Stool Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020-2034
    • 15.2.1. Consumables
    • 15.2.2. Analyzers
  • 15.3. Market Attractiveness, by Product Type
  • 15.4. Market Value Forecast, by Test Type, 2020-2034
    • 15.4.1. Occult Blood Test
    • 15.4.2. Ova and Parasites Test
    • 15.4.3. Fecal Biomarkers Test
    • 15.4.4. Others (Bacteria Test, etc.)
  • 15.5. Market Attractiveness, by Test Type
  • 15.6. Market Value Forecast, by Indication, 2020-2034
    • 15.6.1. Infection
    • 15.6.2. Inflammatory Bowel Disease
    • 15.6.3. Gastroesophageal Reflux Disease
    • 15.6.4. Cancer
    • 15.6.5. Others (Poor Absorption Problems, etc.)
  • 15.7. Market Attractiveness, by Indication
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Diagnostic Centers & laboratories
    • 15.8.3. Academic Institutes
    • 15.8.4. Research Centers & Organizations
    • 15.8.5. Others (Homecare Settings, etc.)
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product Type
    • 15.11.2. By Test Type
    • 15.11.3. By Indication
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Beckman Coulter, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Bio-Rad Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. BioMerieux Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Cardinal Health, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Cenogenics Corporation
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Epitope Diagnostics, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. ScheBo Biotech AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Quest Diagnostics
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Genova Diagnostics
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview